Surgical Vs Transcatheter Aortic Valve Replacement in Young Patients

NANot yet recruitingINTERVENTIONAL

Enrollment

1,180

Participants

Timeline

Start Date

May 15, 2025

Primary Completion Date

November 30, 2027

Study Completion Date

November 30, 2031

Conditions

Symptomatic Severe Aortic Stenosis

Interventions

DEVICE

Myval balloon-expandable THV Series

Patients receive Myval balloon-expandable THV Series (TAVR)

DEVICE

Surgical bioprosthetic valve

Patients receive any surgical bioprosthetic valve commercially available at the clinical investigation site (SAVR)

All Listed Sponsors

lead

Ceric Sàrl

INDUSTRY

NCT06861361 - Surgical Vs Transcatheter Aortic Valve Replacement in Young Patients | Biotech Hunter | Biotech Hunter